Filing Details
- Accession Number:
- 0001203311-20-000142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 19:41:20
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 19:41:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1241357 | I Jean Liu | 21823 30Th Drive Se Bothell WA 98021 | Gc/Evp, Leg Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-14 | 5,000 | $35.95 | 63,642 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,641 | $193.72 | 62,001 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 600 | $194.80 | 61,401 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 300 | $196.03 | 61,101 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 1,522 | $197.14 | 59,579 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-12-14 | 937 | $198.17 | 58,642 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-12-16 | 1,624 | $35.95 | 60,266 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2020-12-16 | 1,624 | $0.00 | 1,624 | $35.95 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-12-14 | 5,000 | $0.00 | 5,000 | $35.95 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,100 | 2024-12-01 | No | 4 | M | Direct | |
| 39,876 | 2024-12-01 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $193.31 to $194.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $194.51 to $194.95. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $195.77 to $196.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $196.91 to $197.89. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $197.98 to $198.40. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 11/17/15 and then monthly thereafter until all options were fully vested on 11/17/18.
Billionaire Hedge Funds
